Theranos Under Scrutiny After WSJ Criticism

at 9:00 AM
 (Andrew Burton/Getty Images)

Bay Area-based Theranos is coming under scrutiny after a Wall Street Journal article questioned the accuracy of the company's blood-testing technology. Since the article, plans for a $350 million partnership with Safeway fell through. Theranos, which is valued at $9 billion, hired a high-profile Supreme Court lawyer and is weighing a defamation lawsuit against the paper. We'll get the latest on Theranos and its recent interactions with the FDA and Capitol Hill.

Sponsored

Sponsored

Volume
KQED Live
Live Stream
Log In ToPledge-Free Stream
LATEST NEWSCAST
KQED
NPR
Live Stream information currently unavailable.
Share
LATEST NEWSCAST
KQED
NPR
KQED Live

Live Stream

Live Stream information currently unavailable.